Literature DB >> 5321112

The effectiveness of combinations of antileukemic agents in inducing and maintaining remission in children with acute leukemia.

E Frei, M Karon, R H Levin, E J Freireich, R J Taylor, J Hananian, O Selawry, J F Holland, B Hoogstraten, I J Wolman, E Abir, A Sawitsky, S Lee, S D Mills, E O Burgert, C L Spurr, R B Patterson, F G Ebaugh, G W James, J H Moon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5321112

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  55 in total

1.  Two hundred years of cancer research.

Authors:  Vincent T DeVita; Steven A Rosenberg
Journal:  N Engl J Med       Date:  2012-05-30       Impact factor: 91.245

Review 2.  Genetics and mechanisms of NT5C2-driven chemotherapy resistance in relapsed ALL.

Authors:  Chelsea L Dieck; Adolfo Ferrando
Journal:  Blood       Date:  2019-03-25       Impact factor: 22.113

Review 3.  Incorporating tyrosine kinase inhibitors into treatment regimens for AML and ALL: is there a right or wrong way?

Authors:  Farhad Ravandi
Journal:  Curr Hematol Malig Rep       Date:  2014-06       Impact factor: 3.952

Review 4.  Chemotherapy of acute leukemia in childhood.

Authors:  K K Khanna
Journal:  Indian J Pediatr       Date:  1968-12       Impact factor: 1.967

5.  Cyclic chemotherapy in childhood acute leukaemia.

Authors:  M L Willoughby; H C Laurie
Journal:  Arch Dis Child       Date:  1968-04       Impact factor: 3.791

6.  Leukemia in children.

Authors: 
Journal:  Calif Med       Date:  1971-04

7.  A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity.

Authors:  Adam C Palmer; Christopher Chidley; Peter K Sorger
Journal:  Elife       Date:  2019-11-19       Impact factor: 8.140

8.  Current issues in the management of children with acute lymphocytic leukaemia.

Authors:  D Pinkel
Journal:  Postgrad Med J       Date:  1985-02       Impact factor: 2.401

Review 9.  Targeting minimal residual disease: a path to cure?

Authors:  Marlise R Luskin; Mark A Murakami; Scott R Manalis; David M Weinstock
Journal:  Nat Rev Cancer       Date:  2018-01-29       Impact factor: 60.716

10.  Enhanced antitumor activity of combinations of free and HPMA copolymer-bound drugs.

Authors:  J Hongrapipat; P Kopecková; S Prakongpan; J Kopecek
Journal:  Int J Pharm       Date:  2007-09-22       Impact factor: 5.875
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.